article Open AccessTop 1% cited
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
Gut · 2021 · Vol. 70(4) · pp. 698–706
Yun Kit Yeoh(Chinese University of Hong Kong)Tao Zuo(Chinese University of Hong Kong)Grace Lui(Chinese University of Hong Kong)Fen Zhang(Chinese University of Hong Kong)Qin Liu(Chinese University of Hong Kong)Amy Y. L. Li(Chinese University of Hong Kong)Arthur Chung(Chinese University of Hong Kong)Chun Pan Cheung(Chinese University of Hong Kong)Eugene Y. K. Tso(United Christian Hospital)Kitty SC Fung(United Christian Hospital)Veronica Chan(United Christian Hospital)Lowell Ling(Chinese University of Hong Kong)Gavin M. Joynt(Chinese University of Hong Kong)David Hui(Chinese University of Hong Kong)Kai Ming Chow(Chinese University of Hong Kong)Susanna S. Ng✉(Chinese University of Hong Kong)Susanna S. Ng(Chinese University of Hong Kong)Timothy Chun-Man Li(Chinese University of Hong Kong)Rita W. Y. Ng(Chinese University of Hong Kong)Terry Cheuk‐Fung Yip(Chinese University of Hong Kong)Grace Lai–Hung Wong(Chinese University of Hong Kong)Francis K.L. Chan(Chinese University of Hong Kong)Chun Kwok Wong(Chinese University of Hong Kong)Paul K.S. Chan(Chinese University of Hong Kong)Siew C Ng✉(Chinese University of Hong Kong)Siew C Ng(Chinese University of Hong Kong)
Abstract
Associations between gut microbiota composition, levels of cytokines and inflammatory markers in patients with COVID-19 suggest that the gut microbiome is involved in the magnitude of COVID-19 severity possibly via modulating host immune responses. Furthermore, the gut microbiota dysbiosis after disease resolution could contribute to persistent symptoms, highlighting a need to understand how gut microorganisms are involved in inflammation and COVID-19.
Gut microbiota and healthCOVID-19 Clinical Research StudiesClostridium difficile and Clostridium perfringens researchDysfunctional familyCoronavirus disease 2019 (COVID-19)Immune systemDiseaseImmunologyGut flora2019-20 coronavirus outbreakMedicineInternal medicinePathology
MeSH terms
Gastrointestinal MicrobiomeCOVID-19SARS-CoV-2AdultBacteriaC-Reactive ProteinDNA, BacterialFemaleHong KongHumansImmunityMaleSeverity of Illness IndexTransferasesCytokines
Funding
- Food and Health Bureau
- Health and Medical Research Fund
Citations
1,364
FWCI
99.24
field-weighted impact
References
47
Percentile
100%
vs. same field & year
Citations per year
Cited by
Long COVID: major findings, mechanisms and recommendations
Nature Reviews Microbiology · 2023 · 3,933 citations
References
MetaPhlAn2 for enhanced metagenomic taxonomic profiling
Nature Methods · 2015 · 2,390 citations
<i>Faecalibacterium prausnitzii</i> is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Proceedings of the National Academy of Sciences · 2008 · 4,255 citations
Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
Neurobiology of Aging · 2016 · 1,327 citations
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
Frontiers in Immunology · 2019 · 3,571 citations
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
The Lancet · 2020 · 28,983 citations
The trinity of COVID-19: immunity, inflammation and intervention
Nature reviews. Immunology · 2020 · 4,600 citations
Immunology of COVID-19: Current State of the Science
Immunity · 2020 · 1,775 citations
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Gastroenterology · 2020 · 1,576 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
